During the past decade, Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" #1 sponsor was "NCIC Clinical Trials Group" with 4 trials, followed by "Pfizer" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Odonate Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" are "Lymphoma" (3 trials), "Advanced Breast Cancer" (1 trials), "Advanced Gastric Cancer" (1 trials), "Advanced/Metastatic Non-Small Cell Lung Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" in a lesser frequency.

Most popular intervention types in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" are "Drug" (6 trials), "Biological" (3 trials), "Dietary Supplement" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "CHOP regimen" (1 trials), "Capecitabine" (1 trials), "Enzalutamide" (1 trials), "Juven" (1 trials) and "Non-Juven Supplement" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" are 8 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".